Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Inventory Average (2019 - 2025)

Historic Inventory Average for Organogenesis Holdings (ORGO) over the last 7 years, with Q3 2025 value amounting to $36.3 million.

  • Organogenesis Holdings' Inventory Average rose 3469.28% to $36.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.3 million, marking a year-over-year increase of 3469.28%. This contributed to the annual value of $27.2 million for FY2024, which is 270.76% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Inventory Average stood at $36.3 million, which was up 3469.28% from $31.2 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Inventory Average high stood at $36.3 million for Q3 2025, and its period low was $23.0 million during Q2 2022.
  • Moreover, its 5-year median value for Inventory Average was $27.3 million (2021), whereas its average is $27.3 million.
  • Its Inventory Average has fluctuated over the past 5 years, first plummeted by 2050.08% in 2022, then soared by 3469.28% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Inventory Average stood at $27.3 million in 2021, then decreased by 9.26% to $24.7 million in 2022, then rose by 13.53% to $28.1 million in 2023, then decreased by 5.17% to $26.6 million in 2024, then surged by 36.37% to $36.3 million in 2025.
  • Its last three reported values are $36.3 million in Q3 2025, $31.2 million for Q2 2025, and $27.8 million during Q1 2025.